- Zacks•22 days ago
Achillion Pharmaceuticals, Inc. (ACHN) announced that it has received a milestone payment of $15 million from Johnson & Johnson's (JNJ) pharma wing, Janssen for the initiation of patient enrollment in the OMEGA-1 phase IIb global study of JNJ-4178.
- TheStreet.com•last month
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
- Motley Fool•2 months ago
Achillion's foray outside of hepatitis C hits a snag.
ADA.F: Summary for ACHILLION PHARMACEUTICALS - Yahoo Finance
Achillion Pharmaceuticals, Inc. (ADA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 8:06AM CET. Market open.
|Bid||3.76 x 43600|
|Ask||3.84 x 42000|
|Day's range||3.75 - 3.75|
|52-week range||3.74 - 8.24|
|PE ratio (TTM)||76.57|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|